In September’s conversation in Obstetrics and Gynecology we talk to Dr Scott White, a maternal fetal medicine specialist from Perth about the Western Australian Prevention of Preterm Birth Initiative. Ted and Rachael discuss cervical length screening in low and high risk populations. Then we have a quick chat with Dr Anders Faber-Swensson, a general O&G about the evidence around fetal fibronectin. Peaceman, Alan M., et al. "Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial." American journal of obstetrics and gynecology 177.1 (1997): 13-18. Berghella, Vincenzo, and Gabriele Saccone. "Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials." American journal of obstetrics and gynecology 215.4 (2016): 431-438. Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD006843. DOI: 10.1002/14651858.CD006843.pub2 Journal club discusses 3 articles related to preterm birth: Newnham, John P., et al. "Reducing preterm birth by a statewide multifaceted program: an implementation study." American journal of obstetrics and gynecology 216.5 (2017): 434-442. Liu, Can, et al. "Prenatal parental depression and preterm birth: a national cohort study." BJOG: An International Journal of Obstetrics & Gynaecology 123.12 (2016): 1973-1982. Norman, Jane Elizabeth, et al. "Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial." The Lancet 387.10033 (2016): 2106-2116.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related